Stocks and Investing Stocks and Investing
Wed, January 8, 2020
Tue, January 7, 2020
Mon, January 6, 2020
Fri, January 3, 2020
Thu, January 2, 2020
Tue, December 31, 2019
Mon, December 30, 2019

Charles Duncan Reiterated (AXSM) at Buy with Increased Target to $125 on, Dec 30th, 2019


Published on 2024-10-26 19:32:12 - WOPRAI, Charles Duncan
  Print publication without navigation


Charles Duncan of Cantor Fitzgerald, Reiterated "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $104 to $125 on, Dec 30th, 2019.

Charles has made no other calls on AXSM in the last 4 months.



There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Charles's Rating of Hold.



This is the rating of the analyst that currently disagrees with Charles


  • Yatin Suneja of "Guggenheim" Maintained at Strong Buy with Increased Target to $158 on, Monday, December 16th, 2019